Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

30.75p
   
  • Change Today:
    -0.50p
  • 52 Week High: 48.10p
  • 52 Week Low: 29.75p
  • Currency: UK Pounds
  • Shares Issued: 361.48m
  • Volume: 430,670
  • Market Cap: £111.15m

Latest ShareCast News

Creo Medical reports year of solid progress

By Josh White

Date: Wednesday 26 Jun 2024

(Sharecast News) - Surgical endoscopy medical device specialist Creo Medical Group reported solid progress over the last 12 months in an update on Wednesday, as it leveraged funds from the March 2023 equity raise to advance its strategic goals.

Creo device used in 'groundbreaking' lung cancer procedure

By Josh White

Date: Friday 01 Mar 2024

(Sharecast News) - Creo Medical Group announced a significant milestone in the field of minimally-invasive surgical endoscopy for cancer patients on Friday, with its 'MicroBlate Flex' device.

Creo Medical FY revenues up double digits

By Iain Gilbert

Date: Wednesday 07 Feb 2024

(Sharecast News) - Medical device company Creo Medical said on Wednesday that 2023 was "a pivotal year" for the firm, with new products supporting "strong growth" and leading to a double-digit jump in group revenues.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 30.75p
Change Today -0.50p
% Change -1.60 %
52 Week High 48.10p
52 Week Low 29.75p
Volume 430,670
Shares Issued 361.48m
Market Cap £111.15m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
9.09% below the market average9.09% below the market average9.09% below the market average9.09% below the market average9.09% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Price Trend
62.4% below the market average62.4% below the market average62.4% below the market average62.4% below the market average62.4% below the market average
13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average13.51% below the sector average
Income Not Available
Growth
21.60% above the market average21.60% above the market average21.60% above the market average21.60% above the market average21.60% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 26-Jul-2024

Time Volume / Share Price
16:21 3,217 @ 30.96p
16:18 1,000 @ 30.68p
15:54 224 @ 30.65p
15:52 2,403 @ 30.96p
15:37 9,869 @ 30.97p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page